Effects of ethinylestradiol/norgestimate, with or without metformin, on metabolic risk factors and endothelial function in overweight women with polycystic ovary syndrome
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.